Bausch Health Companies Inc.
BHC· NYSE
Released Aug 2, 2023, after the close
10-Q filed Aug 3, 2023, 34 days after period end · 0000885590-23-000028
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Revenue | $2.17B | $1.97B | $2.10B | $1.66B |
| Net Income | $26.00M | -$145.00M | -$595.00M | -$326.00M |
| EPS Diluted |
Bausch Health Companies Inc. · CIK 885590 · Engraved from SEC EDGAR
| $0.07 |
| -$0.40 |
| -$1.66 |
| -$0.92 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.